Patents by Inventor Andrew Stephen Lee

Andrew Stephen Lee has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Identification and uses of vasculature forming progenitor cells and progenitor cell combinations
    Patent number: 11369641
    Abstract: Methods, compositions, and kits for producing functional blood vessels, and progenitors thereof are provided. Human disorders of the vascular system are treated by reconstitution of functional vessels in vivo through co-transplantation with supporting niche stromal cells for treatment of ischemic injury in the peripheral limbs and heart. The cell populations of the invention, when engrafted into a recipient, anastomose with host vasculature and regenerate functional blood vessels.
    Type: Grant
    Filed: August 25, 2017
    Date of Patent: June 28, 2022
    Assignee: The Board of Trustees of the Leland Stanford Junior University
    Inventors: Charles K. F. Chan, Andrew Stephen Lee, Michael T. Longaker, Irving L. Weissman, Joseph Wu, Divya Nag, Eun Young Seo
  • IDENTIFICATION AND USES OF VASCULATURE FORMING PROGENITOR CELLS AND PROGENITOR CELL COMBINATIONS
    Publication number: 20190183940
    Abstract: Methods, compositions, and kits for producing functional blood vessels, and progenitors thereof are provided. Human disorders of the vascular system are treated by reconstitution of functional vessels in vivo through co-transplantation with supporting niche stromal cells for treatment of ischemic injury in the peripheral limbs and heart. The cell populations of the invention, when engrafted into a recipient, anastomose with host vasculature and regenerate functional blood vessels.
    Type: Application
    Filed: August 25, 2017
    Publication date: June 20, 2019
    Inventors: Charles K.F. Chan, Andrew Stephen Lee, Michael T. Longaker, Irving L. Weissman, Joseph Wu, Divya Nag, Eun Young Seo
  • Cardiomyocytes From Induced Pluripotent Stem Cells From Patients and Methods of Use Thereof
    Publication number: 20170058263
    Abstract: Human somatic cells obtained from individuals with a genetic heart condition are reprogrammed to become induced pluripotent stem cells (iPS cells), and differentiated into cardiomyocytes for use in analysis, screening programs, and the like.
    Type: Application
    Filed: June 10, 2016
    Publication date: March 2, 2017
    Inventors: Ning Sun, Michael T. Longaker, Robert C. Robbins, Joseph Wu, Feng Lan, Andrew Stephen Lee, Paul W. Burridge
  • Cardiomyocytes from induced pluripotent stem cells from patients and methods of use thereof
    Patent number: 9395354
    Abstract: Human somatic cells obtained from individuals with a genetic heart condition are reprogrammed to become induced pluripotent stem cells (iPS cells), and differentiated into cardiomyocytes for use in analysis, screening programs, and the like.
    Type: Grant
    Filed: July 20, 2012
    Date of Patent: July 19, 2016
    Assignee: The Board of Trustees of the Leland Stanford Junior University
    Inventors: Ning Sun, Michael T. Longaker, Robert C. Robbins, Joseph Wu, Feng Lan, Andrew Stephen Lee, Paul W. Burridge
  • CARDIOMYOCYTES FROM INDUCED PLURIPOTENT STEM CELLS FROM PATIENTS AND METHODS OF USE THEREOF
    Publication number: 20130029866
    Abstract: Human somatic cells obtained from individuals with a genetic heart condition are reprogrammed to become induced pluripotent stem cells (iPS cells), and differentiated into cardiomyocytes for use in analysis, screening programs, and the like.
    Type: Application
    Filed: July 20, 2012
    Publication date: January 31, 2013
    Inventors: Ning Sun, Michael T. Longaker, Robert C. Robbins, Joseph Wu, Feng Lan, Andrew Stephen Lee, Paul W. Burridge